AU2001284382A1 - A controlled release anti-inflammatory formulation and a process for the preparation thereof - Google Patents

A controlled release anti-inflammatory formulation and a process for the preparation thereof

Info

Publication number
AU2001284382A1
AU2001284382A1 AU2001284382A AU8438201A AU2001284382A1 AU 2001284382 A1 AU2001284382 A1 AU 2001284382A1 AU 2001284382 A AU2001284382 A AU 2001284382A AU 8438201 A AU8438201 A AU 8438201A AU 2001284382 A1 AU2001284382 A1 AU 2001284382A1
Authority
AU
Australia
Prior art keywords
preparation
controlled release
release anti
inflammatory formulation
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284382A
Other languages
English (en)
Inventor
Manutosh Manohar Acharya
Milind Kesharlal Biyani
Shripad Rhushikesh Jathar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajanta Pharma Ltd
Original Assignee
Ajanta Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajanta Pharma Ltd filed Critical Ajanta Pharma Ltd
Publication of AU2001284382A1 publication Critical patent/AU2001284382A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
AU2001284382A 2000-06-20 2001-06-18 A controlled release anti-inflammatory formulation and a process for the preparation thereof Abandoned AU2001284382A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN561MU2000 IN190963B (nl) 2000-06-20 2000-06-20
IN561/MUM/2000 2000-06-20
PCT/IN2001/000117 WO2001097775A2 (en) 2000-06-20 2001-06-18 Controlled release anti-inflammatory formulation

Publications (1)

Publication Number Publication Date
AU2001284382A1 true AU2001284382A1 (en) 2002-01-02

Family

ID=11097256

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284382A Abandoned AU2001284382A1 (en) 2000-06-20 2001-06-18 A controlled release anti-inflammatory formulation and a process for the preparation thereof

Country Status (6)

Country Link
US (1) US20020012702A1 (nl)
EP (1) EP1406635A2 (nl)
AU (1) AU2001284382A1 (nl)
BR (1) BR0111879A (nl)
IN (1) IN190963B (nl)
WO (1) WO2001097775A2 (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101227893A (zh) * 2005-07-20 2008-07-23 万能药生物有限公司 新型药物控释剂型环加氧酶抑制剂
BE1018280A3 (fr) * 2008-09-09 2010-08-03 Squarepoint Pointcarre Sprl Composition de nimesulide a liberation prolongee.
TR201906487A1 (tr) * 2019-04-30 2020-11-23 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Tolperi̇zon ve ni̇mesuli̇d kombi̇nasyonlari i̇çeren farmasöti̇k kompozi̇syonlar

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9804993A (pt) * 1998-11-10 2000-06-06 Panacea Biotec Ltd Composição antialérgica e antiinflamatória
EP1147767A1 (en) * 2000-04-22 2001-10-24 J.B. Chemicals & Pharmaceuticals Ltd. Controlled release formulations of nimesulide and a process for the manufacture thereof

Also Published As

Publication number Publication date
US20020012702A1 (en) 2002-01-31
EP1406635A2 (en) 2004-04-14
WO2001097775A3 (en) 2002-05-30
IN190963B (nl) 2003-09-06
WO2001097775A2 (en) 2001-12-27
BR0111879A (pt) 2003-06-24

Similar Documents

Publication Publication Date Title
AU2001290825A1 (en) Controlled release formulations and methods for their production and use
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2002248377A1 (en) A controlled release pharmaceutical composition
AU3977099A (en) Controlled release oral dosage form
AU4477001A (en) Injectable sustained release pharmaceutical composition and processes for preparing the same
AU2791599A (en) Extended release dosage form
AU2001224716A1 (en) A medicinal aerosol formulation
AU2001226233A1 (en) A medicinal aerosol formulation
AU5164300A (en) Quick release buckles
AU2001284324A1 (en) Controlled release formulation of erythromycin or a derivative thereof
AU7466900A (en) A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU2001224718A1 (en) A medicinal aerosol formulation
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
AU5246901A (en) A coating composition for facilitating controlled release
AU2001259318A1 (en) A medicinal aerosol formulation
AU7887400A (en) A slow release pharmaceutical composition
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2001284382A1 (en) A controlled release anti-inflammatory formulation and a process for the preparation thereof
AU2691200A (en) Isoxazoline compounds and processes for the preparation thereof
AU2002218494A1 (en) Medicinal compositions and process for producing the same
AU2001227531A1 (en) A medicinal aerosol formulation
AU2001247123A1 (en) A medicinal aerosol formulation
AU2001252254A1 (en) 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparationthereof and use thereof
AU2001260083A1 (en) New pharmaceutical composition and the process for its preparation